SEC Form 4 · accession 0001209191-19-019237
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kim D Blickenstaff
Officer — Executive Chairman · Director
Period of report
Mar 11, 2019
Accepted (ET)
Mar 13, 2019 · 7:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 11, 2019 | S | 184,046 | $64.89 | D | 1,007,704 | I | See Footnote |
| Common StockF3,F2 | Mar 11, 2019 | S | 15,954 | $65.67 | D | 991,750 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $64.50 and $65.4925.
- F2The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
- F3The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $65.51 and $65.795.